Medical device maker Trinity Biotech plc (TRIB) said U.S. health regulators approved its blood-clot analyzer, Destiny Max, sending its shares soaring 28 percent to a new 52-week high.
The device, already sold in Europe and other international markets, would be launched in the United States with immediate effect, the company said.
Strong Uptrend
TRINITY BIOTECH PLC ADR (NASDAQ:TRIB)
Smart Scan Chart Analysis continues positive longer term. Look for this market to remain firm. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.
Market Club has a very interesting take on how TRIB is playing out after the past volume surge. The “Trade Triangles” paint the picture. Click Here to see what Market Club has to say for FREE.
